• Lior Leibou, Tomer Perlok, Rivi Haiat Factor, Eyal Leibovitz, Jacob Frand, Stav Leibou, Dror Sadan, and Mordechai Shimonov.
• Department of Plastic Surgery Unit, Wolfson Medical Center, Holon, Israel.
• Isr Med Assoc J. 2020 Jun 1; 22 (6): 374-377.

BackgroundThe effect of weight reduction following bariatric surgery is already well known.ObjectivesTo investigate the effects of abdominoplasty on metabolic markers indicative of weight loss.MethodsThe authors prospectively enrolled consecutive obese patients after laparoscopic sleeve gastrectomy. They were candidates for post-bariatric surgery abdominoplasty. The authors measured metabolic markers one day prior to surgery, 24 hours after, and 3 months following surgery. They recorded medical and demographic parameters.ResultsSixteen patients were recruited for participation in the study. Mean age was 47 years and 88% of the patients were female. Bariatric surgery achieved a mean decline in body mass index of 13.8 kg/m2. All patients underwent abdominoplasty. Leptin and insulin levels were slightly increased at 3 months postoperative. No significant changes were observed in glucose, hemoglobin, or triglycerides throughout the study.ConclusionsIn a cohort of obese patients undergoing laparoscopic sleeve gastrectomy followed by abdominoplasty, no significant changes were noted in a patient's metabolic profiles. The results suggest that abdominoplasty has no effect on the metabolic markers tested in contrast to other reports; however, the cosmetic, behavioral, and psychological advantages of abdominoplasty are well established.

19 keywords...

hide…